4.7 Review

Enterovirus A71 Vaccines

期刊

VACCINES
卷 9, 期 3, 页码 -

出版社

MDPI
DOI: 10.3390/vaccines9030199

关键词

Enterovirus A71; hand; foot and mouth disease (HFMD); vaccine; Sinovac

资金

  1. National Institutes of Health [R01 GM126833]
  2. Research Center for Emerging Viral Infections from The Featured Areas Research Center Program
  3. Ministry of Science and Technology, Taiwan [MOST 108-3017-F 182-001]

向作者/读者索取更多资源

Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina, with potential neurological complications and death. Vaccination is the most efficient way to control virus infection, with multiple types of vaccines currently in development and use.
Enterovirus A71 (EV-A71) is a major causative agent of hand, foot, and mouth disease (HFMD) and herpangina. Moreover, EV-A71 infection can lead to neurological complications and death. Vaccination is the most efficient way to control virus infection. There are currently three inactivated, whole EV-A71 vaccines licensed by the China NMPA (National Medical Products Administration). Several other types of vaccines, such as virus-like particles and recombinant VP1 (capsid protein), are also under development. In this review, we discuss recent advances in the development of EV-A71 vaccines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据